Charcot-Marie-Tooth disease type 1F
Charcot-Marie-Tooth disease type 1F
Explore linked clinical trials. Standard reference: MONDO:001190229 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neurofilament Light Chain And Voice Acoustic Analyses In Dementia Diagnosis | Alzheimer disease, Charcot-Marie-Tooth disease type 1F, Nerve Degeneration, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Not stated | 2026-10-08 | NCT06339190 | |
| Study on Thiamine Supplementation to REduce braiN Injury Associated With Chronic Alcohol Use in Outpatients With Alcohol Use Disorder | Alcohol Use Disorder, Charcot-Marie-Tooth disease type 1F, Chemically-Induced Disorders, alcohol-related disorders, psychiatric disorder, substance-related disorder | Not yet recruiting | Phase 2 | 2026-09-28 | NCT07844720 | |
| Developing New Ways to Detect Respiratory Impairment Early in ALS | Charcot-Marie-Tooth disease type 1F, Hypercapnia, Hypoxia, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Respiratory Aspiration, Signs and Symptoms, Signs and Symptoms, Respiratory, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, disease, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, respiratory failure, respiratory system disorder, spinal cord disorder | Recruiting | Not stated | 2026-09-28 | NCT07844590 | |
| Natural History Study for Charcot Marie Tooth Disease | Charcot-Marie-Tooth Disease, Type IA, Charcot-Marie-Tooth Disease, Type IB, Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease axonal type 2H, Charcot-Marie-Tooth disease axonal type 2N, Charcot-Marie-Tooth disease type 1C, Charcot-Marie-Tooth disease type 1D, Charcot-Marie-Tooth disease type 1E, Charcot-Marie-Tooth disease type 1F, Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2A1, Charcot-Marie-Tooth disease type 2A2, Charcot-Marie-Tooth disease type 2B1, Charcot-Marie-Tooth disease type 2B2, Charcot-Marie-Tooth disease type 2B5, Charcot-Marie-Tooth disease type 2D, Charcot-Marie-Tooth disease type 2E, Charcot-Marie-Tooth disease type 2I, Charcot-Marie-Tooth disease type 2J, Charcot-Marie-Tooth disease type 2R, Charcot-Marie-Tooth disease type 2T, Charcot-Marie-Tooth disease type 2Y, Charcot-Marie-Tooth disease type 4A, Charcot-Marie-Tooth disease type 4B1, Charcot-Marie-Tooth disease type 4B2, Charcot-Marie-Tooth disease type 4B3, Charcot-Marie-Tooth disease type 4C, Charcot-Marie-Tooth disease type 4D, Charcot-Marie-Tooth disease type 4E, Charcot-Marie-Tooth disease type 4H, Charcot-Marie-Tooth disease, Type 2A, Charcot-Marie-Tooth disease, Type 2K, Charcot-Marie-Tooth disease, Type 4A, axonal form, Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Emery-Dreifuss muscular dystrophy 2, autosomal dominant, Hereditary Motor and Sensory Neuropathy, Type IIC, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autosomal dominant Charcot-Marie-Tooth disease type 2K, central nervous system malformation, disease, hereditary disease, hereditary motor and sensory neuropathy, hereditary neuropathy with liability to pressure palsies, inherited neurodegenerative disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, peripheral nervous system disorder, polyneuropathy | Recruiting | Not stated | 2026-09-17 | NCT05902351 | |
| ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis | CNS demyelinating autoimmune disease, Charcot-Marie-Tooth disease type 1F, Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic progressive multiple sclerosis, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Active, not recruiting | Phase 2 / Phase 3 | 2026-09-08 | NCT04695080 | |
| Lithium for Parkinson's: an Extension Trial | Charcot-Marie-Tooth disease type 1F, Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Enrolling by invitation | Phase 1 / Phase 2 | 2026-08-25 | NCT06592014 | |
| Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-2) | Charcot-Marie-Tooth disease type 1F, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence | Active, not recruiting | Phase 3 | 2026-08-18 | NCT05156281 | |
| Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1) | Charcot-Marie-Tooth disease type 1F, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence | Active, not recruiting | Phase 3 | 2026-08-18 | NCT05147220 | |
| Kinetics and Prognostic Value of NeuroFilament Light in Post-cardiac Arrest: A Prospective Multicenter Study | Charcot-Marie-Tooth disease type 1F, Coma, Consciousness Disorders, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Unconsciousness, cardiac arrest, cardiovascular disorder, heart disorder, nervous system disorder | Not yet recruiting | Not stated | 2026-08-12 | NCT07760636 | |
| Non-Invasive Brain Stimulation to Improve Language in Down Syndrome. | Abnormalities, Multiple, Charcot-Marie-Tooth disease type 1F, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Down syndrome, Neurobehavioral Manifestations, Neurologic Manifestations, chromosomal disorder, hereditary disease, intellectual disability, nervous system disorder | Recruiting | Not applicable | 2026-07-24 | NCT07044804 | |
| The Biomarkers in the Hyperbaric Oxygen Brain Injury Treatment Trial (BioHOBIT) | Brain Injuries, Traumatic, Charcot-Marie-Tooth disease type 1F, Craniocerebral Trauma, brain disorder, brain injury, central nervous system disorder, injury, nervous system disorder, nervous system injury | Recruiting | Not stated | 2026-06-22 | NCT04855396 | |
| Association of Intraoperative Blood Pressure Excursions Below Cerebral Autoregulatory Boundaries With Organ Injury Following Major Noncardiac Surgery | Charcot-Marie-Tooth disease type 1F, cardiovascular disorder, hypotensive disorder, injury, nervous system disorder, nervous system injury, vascular disorder | Active, not recruiting | Not stated | 2026-05-27 | NCT05336864 | |
| Pulse Pressure and Outcomes After Out-of-Hospital Cardiac Arrest | Charcot-Marie-Tooth disease type 1F, Out-of-Hospital Cardiac Arrest, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, brain disorder, brain injury, cardiac arrest, cardiovascular disorder, central nervous system disorder, heart disorder, ischemia reperfusion injury, nervous system disorder, post-cardiac arrest syndrome, vascular disorder | Active, not recruiting | Not stated | 2026-05-22 | NCT07586878 | |
| ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS | CNS demyelinating autoimmune disease, Charcot-Marie-Tooth disease type 1F, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder, relapsing-remitting multiple sclerosis | Recruiting | Phase 4 | 2026-05-15 | NCT06733922 | |
| DIV-AD BARCELONA: Alzheimer's Blood-Based Biomakers for a Diverse Community | Alzheimer disease, Charcot-Marie-Tooth disease type 1F, Cognition Disorders, Cognitive Dysfunction, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Plaque, Amyloid, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Not yet recruiting | Not stated | 2026-04-13 | NCT07521722 | |
| Impact of Exercise Training on Serum Neurofilament Light Chain (NfL), Brain Volumetry, and Functional Outcomes in Multiple Sclerosis | CNS demyelinating autoimmune disease, Charcot-Marie-Tooth disease type 1F, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Not yet recruiting | Not applicable | 2026-04-09 | NCT07520812 | |
| Early Detection of Brain Injury After Congenital Heart Surgery in Infants | Cardiovascular Abnormalities, Charcot-Marie-Tooth disease type 1F, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypoxia, Hypoxia, Brain, Hypoxic Brain Damage, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, brain disorder, cardiovascular disorder, central nervous system disorder, congenital heart disease, heart disorder, nervous system disorder | Enrolling by invitation | Not stated | 2026-03-10 | NCT07424976 | |
| Natalizumab for the Treatment of People With Inflammatory Demyelination Suggestive of Multiple Sclerosis, or Definite Multiple Sclerosis, at First Presentation (AttackMS) | CNS demyelinating autoimmune disease, Charcot-Marie-Tooth disease type 1F, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Recruiting | Phase 2 | 2026-01-07 | NCT05418010 | |
| Analysis of NfL and GFAP in Different Dietary Patterns | Charcot-Marie-Tooth disease type 1F | Recruiting | Not stated | 2025-12-31 | NCT07312994 | |
| A Study of a Blood Marker in Newborns With Brain Injury Caused by Lack of Oxygen at Birth | Charcot-Marie-Tooth disease type 1F, Hypoxia, Hypoxia, Brain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, brain disorder, brain hypoxia - ischemia, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, perinatal asphyxia, vascular disorder | Not yet recruiting | Not stated | 2025-12-18 | NCT07292220 | |
| Comparison of Efficacy and Safety in Patients Switching From MabThera® to Rixathon® in Relapsing-Remitting Multiple Sclerosis | CNS demyelinating autoimmune disease, Charcot-Marie-Tooth disease type 1F, Chronic Disease, Disease Attributes, Disease Progression, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic progressive multiple sclerosis, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder, relapsing-remitting multiple sclerosis | Active, not recruiting | Not stated | 2025-11-19 | NCT07235644 | |
| Evaluation of Functional and Biochemical Effectiveness of a Strength Training Protocol in Parkinson's Disease | Charcot-Marie-Tooth disease type 1F, Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Not yet recruiting | Not applicable | 2025-07-31 | NCT07095400 | |
| Biomarkers Associated With Postoperative Cognitive Dysfunction | Charcot-Marie-Tooth disease type 1F, Cognition Disorders, Cognitive Decline, Cognitive Dysfunction, Confusion, Frontotemporal Lobar Degeneration, Neurobehavioral Manifestations, Neurologic Manifestations, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Cognitive Complications, Postoperative Complications, Signs and Symptoms, TDP-43 proteinopathy, brain disorder, central nervous system disorder, cognitive disorder, delirium, dementia, frontotemporal dementia, metabolic disease, nervous system disorder, neurodegenerative disease, proteostasis deficiencies, psychiatric disorder | Active, not recruiting | Not stated | 2025-06-22 | NCT05464355 | |
| Neurofilament Light Chain Correlation With Severity of Symptoms and Cognitive Decline in Mood Disorders | Charcot-Marie-Tooth disease type 1F, mood disorder, psychiatric disorder | Not yet recruiting | Not stated | 2025-03-14 | NCT06877442 | |
| Registry Study of Assistive Devices, Medicines and Healthcare Measures in ALS, SMA and Other Neurological Diseases. | Charcot-Marie-Tooth disease type 1F, Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Recruiting | Not stated | 2025-01-29 | NCT05852418 |